Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer

Supportive Care in Cancer

Volumn 26, Issue 8, 2018, Pages 2503-2509

  Hassan, Hadeel ^a,b   Rompola, M ^a,b   Glaser, A W ^a,b   Kinsey, S E ^a,b   Phillips, R S ^a,c  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cancer; Probiotics; Randomised controlled trials (RCT)

Indexed keywords

PROBIOTIC AGENT;

BACTEREMIA; BIFIDOBACTERIUM; BLOOD CULTURE; CANCER PATIENT; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FUNGEMIA; HUMAN; LACTOBACILLUS; MALIGNANT NEOPLASM; META ANALYSIS; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SEPTICEMIA; SYSTEMATIC REVIEW; ADULT; CHILD; INCIDENCE; NEOPLASM; PATHOLOGY;

ADULT; CHILD; DIARRHEA; HUMANS; INCIDENCE; NEOPLASMS; PROBIOTICS;

EID: 85046022913     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-018-4216-z     Document Type: Review

References (18)

1. Schlundt, J. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. FAO/WHO. 2012 October 2012; Available from: https://web.archive.org/web/20121022161702/http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
2. Holzapfel WH, Haberer P, Geisen R, Björkroth J, Schillinger U (2001) Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73(2 Suppl):365s–373s
3. Goldenberg, J.Z., et al.,(2015) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev, 22(12)
4. Pammi, M. and G. Suresh, Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2017. 28(6)
5. Liu, M.M., et al.,(2017) Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials. PLoS One,12(6)
6. Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S (1988) Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 39(4):435–437
7. Guarner F, Malagelada JR (2003) Role of bacteria in experimental colitis. Best Pract Res Clin Gastroenterol 17(5):793–804
8. Arbuckle RB, Huber SL, Zacker C (2000) The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist 5(3):250–259
9. Dranitsaris G, Maroun J, Shah A (2005) Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol 19(2):83–87
10. Redman MG, Ward EJ, Phillips RS (2014) The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol 25(10):1919–1929
11. H Hassan, M. Rompola, Bob Phillips,(2016) The efficacy and safety of probiotics in people with cancer: an updated systematic review and meta-analysis, PROSPERO
12. Higgins JP et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
13. Loke YK, Price D, Herxheimer A (2007) Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol 7:32
14. Dissemination, C.f.R.a(2008), Systematic Reviews: CRD's guidance for undertaking reviews in health care,University of York: CRD
15. Higgins JP, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 172(1):137–159
16. Team, R,(2015) RStudio: integrated development for R. RStudio, Inc.
17. The CONSORT Statement. 2016; Available from: http://www.consort-statement.org/
18. COMET intitiative. [cited 2017; Available from: http://www.comet-initiative.org/